The literature on this topic is complex: whilst mTOR inhibition has been shown to induce differentiation in myeloid leukaemic cell lines, possibly through prolonging PU1 effects, it has also been shown to preserve an undifferentiated phenotype and long term survival in AML cells in vivo and in vitro [28]. Here, SPI1 is linked to acute myeloid leukemia.